Wei Zhang

Volitinib, a potent and highly selective c‐Met inhibitor, effectively blocks c‐Met signaling and growth in c‐MET amplified gastric cancer patient‐derived tumor xenograft models

Weiguo Qing, Fengmin Zhou, W. Su, 2015, Molecular oncology.

Anti-tumor efficacy of theliatinib in esophageal cancer patient-derived xenografts models with epidermal growth factor receptor (EGFR) overexpression and gene amplification.

Weiguo Qing, Jian-ming Zheng, Yunxin Chen, 2017, Oncotarget.

Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapy

Weiguo Qing, Meifang Zhang, Y. Sai, 2014, Cancer biology & therapy.